GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
16.73
+0.36 (2.20%)
Jan 22, 2026, 4:00 PM EST - Market closed
GH Research Market Cap
GH Research has a market cap or net worth of $1.04 billion as of January 23, 2026. Its market cap has increased by 121.75% in one year.
Market Cap
1.04B
Enterprise Value
745.07M
1-Year Change
121.75%
Ranking
Category
Stock Price
$16.73
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.04B, an increase of 28.46%. That is a compound annual growth rate of 5.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.04B | 31.81% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 1.03B |
| Theravance Biopharma | 1.03B |
| Aktis Oncology | 1.03B |
| Nanobiotix | 1.01B |
| ARS Pharmaceuticals | 998.37M |
| Ventyx Biosciences | 994.46M |
| Iovance Biotherapeutics | 986.47M |
| Annexon | 966.63M |